611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Health Sciences
Resources
Basic InformationLatest News
Certain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryAHA News: Former NFL Players With Lots of Concussions May Have Higher Stroke RiskMore Years Playing Football, More Brain Lesions on MRI: StudyNew Insights Into What Might Drive Parkinson's DiseaseBrain's 'White Matter' Changes in People With AutismWearable Vibration Device May Ease Parkinson's TremorNeurologists' Group Issues New Treatment Guidelines for Early Parkinson'sGene Therapy Could Be Big Advance Against HemophiliaBlood Test Looks at Patients' Whole Genome to Spot Rare Inherited DiseasesSales of Unproven, Unapproved Stem Cell Therapies Are BoomingHow Bilingual Brains Shift Quickly Between LanguagesMouse Study Offers Hope for Gene Therapy Against Parkinson's DiseaseInsomnia Tied to Raised Risk of AneurysmAHA News: Could the Path to Better Brain Health Involve Better Mouth Care?More Americans Are Dying From Parkinson's Disease: StudyTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseResearchers Find Better Way to Fight Breast Cancer That Has Spread to BrainShape, Size of Brain Arteries May Predict Stroke RiskTracking Key Protein Helps Predict Outcomes in TBI PatientsSigns of Early Alzheimer's May Be Spotted in Brain StemCould Cholesterol Help Drive Alzheimer's Disease?Insights Into Genes Driving Epilepsy Could Help With TreatmentFewer American Adults Are Getting Malignant Brain TumorsLong-Term Outlook for Most With Serious Brain Injury Is Better Than ThoughtStroke Prevented His Speech, But Brain Implant Brought It BackWHO Calls for Global Registry of Human Genome EditingScientists Track Spirituality in the Human BrainNew Insights Into How Eating Disorders Alter the BrainGene Differences Could Have Black Patients Undergoing Unnecessary BiopsiesCRISPR Therapy Fights Rare Disease Where Protein Clogs OrgansNew Genetic Insights Into Cause of ALSDeep Brain Stimulation Therapy May Help Parkinson's Patients Long TermAmazon Tribe Could Hold Key to Health of Aging BrainsMan Blind for 40 Years Regains Some Sight Through Gene TherapyNew Insights Into Treating Mild Head Injuries'Ghosts and Guardian Angels': New Insights Into Parkinson's HallucinationsHigher Education Won't Help Preserve the Aging Brain: StudyScientists Create Embryos With Cells From Monkeys, Humans'Game of Thrones' Study Reveals the Power of Fiction on the MindScientists Create Human Tear Glands That Cry in the LabAHA News: How Grief Rewires the Brain and Can Affect Health – and What to Do About ItCould Taking a Swing at Golf Help Parkinson's Patients?Autopsy Study May Explain Why Some COVID Survivors Have 'Brain Fog'Gene Study Probes Origins of Addison's DiseaseCould a Common Prostate Drug Help Prevent Parkinson's?AHA News: Hormones Are Key in Brain Health Differences Between Men and WomenNerve Drug Might Curb Spinal Cord Damage, Mouse Study SuggestsIs There a 'Risk-Taking' Center in the Brain?AHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Can 2 Nutrients Lower Your Risk for Parkinson's?
Questions and AnswersLinksBook Reviews
Related Topics

Medical Disorders
Mental Disorders
Mental Health Professions

Mouse Study Offers Hope for Gene Therapy Against Parkinson's Disease

HealthDay News
by Robert Preidt
Updated: Nov 4th 2021

new article illustration

THURSDAY, Nov. 4, 2021 (HealthDay News) -- An experimental gene therapy to boost the effectiveness of the Parkinson's drug levodopa yielded promising results in mice, researchers report.

As the loss of dopamine-releasing neurons advances in late-stage Parkinson's, levodopa is less able to ease movement problems caused by the disease, which is a progressive disorder of the nervous system.

But a Northwestern University team found that gene therapy targeting the brain region in mice where those neurons are located significantly increased levodopa's benefits.

The gene therapy did this by restoring the neurons' ability to convert levodopa to dopamine, according to the researchers. However, animal research does not always pan out in humans.

Along with their findings about the gene therapy, the investigators offered new insight into why dopamine-releasing neurons are lost in Parkinson's disease patients.

In mice, the researchers found that damage to the mitochondria (the power plants) in dopamine-releasing neurons triggers a sequence of events that resemble what happens to brain circuits in Parkinson's disease.

The findings may help identify people in the earliest stages of Parkinson's and lead to therapies to slow disease progression and treat late-stage disease.

"The development of effective therapies to slow or stop Parkinson's disease progression requires scientists know what causes it," said study author D. James Surmeier, chair of neuroscience at Northwestern's School of Medicine.

"This is the first time there has been definitive evidence that injury to mitochondria in dopamine-releasing neurons is enough to cause a human-like Parkinsonism in a mouse," he said in a university news release.

"Whether mitochondrial damage was a cause or consequence of the disease has long been debated," Surmeier noted. "Now that this issue is resolved, we can focus our attention on developing therapies to preserve their function and slow the loss of these neurons."

The study also provides a model of Parkinson's disease before symptoms appear.

"This new 'human-like' model may help us develop tests that would identify people who are on their way to being diagnosed with Parkinson's disease in five or 10 years," Surmeier said. "Doing so would allow us to get them started early on therapies that could alter disease progression."

The findings were published Nov. 3 in the journal Nature.

More information

The Parkinson's Foundation has more on Parkinson's disease.

SOURCE: Northwestern University, news release, Nov. 3, 2021